Orthofix to Present at Canaccord Genuity Growth Conference
Get Alerts OFIX Hot Sheet
Join SI Premium – FREE
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix International N.V. (NASDAQ: OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that President and Chief Executive Officer Brad Mason will present at the Canaccord Genuity Growth Conference in Boston on Wednesday, August 8, 2018 at 11:00 a.m. ET.
A live audio webcast will be available on the Company’s website at ir.orthofix.com/events.cfm.
About Orthofix
Orthofix International N.V. is a global medical device company focused on musculoskeletal products and therapies. The Company’s mission is to improve patients' lives by providing superior reconstruction and regenerative musculoskeletal solutions to physicians worldwide. Headquartered in Lewisville, Texas, Orthofix’s spine and orthopedic extremities products are distributed in over seventy countries via the Company's sales representatives and distributors. For more information, please visit www.orthofix.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180731005925/en/
Orthofix International N.V.
Investor Contact:
Mark
Quick, 214-937-2924
[email protected]
or
Media
Contact:
Denise Landry, 214-937-2529
[email protected]
Source: Orthofix International N.V.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- XRP Market Volatility Drives Demand for AI Automated Trading as MoneySimpler Expands Access to Quantitative Strategies
- Apeing Announces its Upcoming Crypto Presale Launch on September 8 as Bitcoin News Signals Renewed Market Momentum
- Business, sport and a cause: WhiteBIT Australia hosts the Huddle Up in Melbourne
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share